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GFRa3, a Component of the Artemin Receptor,
Is Required for Migration and Survival
of the Superior Cervical Ganglion
GDNF and neurturin support the survival of a wide vari-
ety of neurons derived from both the central and periph-
eral (PNS) nervous systems, including midbrain dopami-
nergic neurons, autonomic neurons, and sensory neurons
(Lin et al., 1993; Stromberg et al., 1993; Buj-Bello et al.,
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1997), and GFRa3 transduces signals in response to
artemin but not to neurturin or GDNF (Baloh et al., 1998b).GFRa3 is a component of the receptor for the neuro-
Thus, GFRa3 is likely a receptor component specific fortrophic factor artemin. The role of GFRa3 in nervous
artemin. However, the ligand specificities of the GFRasystem development was examined by generating mice
proteins appear complex, differing in the absence andin which the Gfra3 gene was disrupted. The Gfra32/2
presence of Ret. Ret is the only b component that hasmice exhibited severe defects in the superior cervical
been identified to date (Trupp et al., 1996). Ret andganglion (SCG), whereas other ganglia appeared nor-
GFRa coreceptors are expressed in both distinct andmal. SCG precursor cells in the mutant embryos failed
overlapping regions of the developing embryo and theto migrate to the correct position, and they subse-
adult (Baloh et al., 1997; Trupp et al., 1997; Widenfalkquently failed to innervate the target organs. In wild-
et al., 1997).type embryos, Gfra3 was expressed in migrating SCG
The physiological roles of GDNF family members andprecursors, and artemin was expressed in and near
their receptors have been highlighted by the characteris-the SCG. After birth, SCG neurons in the mutant mice
tics of corresponding knockout mice. Mice lacking Retunderwent progressive cell death. These observations
(Schuchardt et al., 1994) show marked similarities tosuggest that GFRa3-mediated signaling is required
those lacking GDNF (Moore et al., 1996; Pichel et al.,both for the rostral migration of SCG precursors and
1996). Both types of mutant mice fail to form a uretericfor the survival of mature SCG neurons.
bud or to undergo metanephric development, and they
lack enteric neurons throughout the digestive tract.
These similarities support the notion that Ret functionsIntroduction
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GFRa2 both show defects in the enteric and parasympa-al., 1998). These factors appear to play important roles
thetic nervous systems (Heuckeroth et al., 1999; Rossiin the survival and differentiation of vertebrate neurons.
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Figure 1. Generation of Gfra3 Knockout Mice
(A) Targeting strategy. The structure of the
Gfra3 gene is shown at the top (K indicates
KpnI). Homologous recombination resulted in
replacement of exons 4±8 of Gfra3 (closed
boxes) by the neomycin resistance gene
(neo).
(B) Southern blot analysis of ES cell lines.
Genomic DNA was digested with KpnI and
subjected to hybridization with the 39 probe
shown in (A). Arrowheads indicate the 25 kb
(wild-type) and 10.5 kb (mutant) fragments.
The cell line indicated by the closed circle is
one of the mutant lines.
(C) Genotype analysis of offspring obtained
from intercrossing of Gfra31/2 heterozygotes.
Analysis was performed by PCR with primers
shown in (A): 59 PCR and 39 PCR1 for the wild-
type allele, and 59 PCR and 39 PCR2 for the
mutant allele. The indicated 780 and 460 bp
fragments represent the wild-type and mu-
tant alleles, respectively.
(D and E) In situ hybridization analysis of
Gfra3 expression in wild-type (D) and mutant
(E) embryos at embryonic day 14.5 (E14.5).
Whereas Gfra3 mRNA was abundant in PNS
ganglia, including the sympathetic chain (SC),
DRG, and trigeminal ganglion (TG), of wild-
type embryos, it was not detected in mutant
embryos. Scale bar, 1 mm.
appears largely restricted to the PNS (to a greater extent of Gfra32/2 mice at the expected frequency of z25% (85/
347) (Figure 1C). The homozygous mutants appeared tothan is that of Gfra1 or Gfra2), being substantial only in
developing peripheral nerves and ganglia (Baloh et al., grow normally and were fertile. In wild-type mice, Gfra3
shows marked expression in ganglia of the PNS, includ-1998a; Naveilhan et al., 1998; Widenfalk et al., 1998;
Worby et al., 1998). We have now examined the role of ing the cranial ganglia, dorsal root ganglia (DRG), and
sympathetic ganglia (Figure 1D) (Jing et al., 1997; BalohGFRa3 in development of the PNS by generating Gfra3
knockout mice. The characteristics of these mice, to- et al., 1998a). In situ hybridization confirmed the absence
of Gfra3 mRNA in these ganglia of homozygous mutantgether with the expression patterns of Gfra3 and artemin
in wild-type animals, suggest that GFRa3 is required embryos (Figure 1E).
for the migration of superior cervical ganglion (SCG)
precursors and for the survival of mature SCG neurons Development of the SCG Is Impaired in Gfra32/2 Mice
The external appearance of the Gfra32/2 mice seemedby acting as a coreceptor for artemin.
normal with the exception that they exhibited ptosis
(Figures 2A and 2B). Given that ptosis can result fromResults
a defect in sympathetic ganglia, the SCG in particular,
we examined the SCG of adult mutant mice. In wild-Generation of GFRa3-Deficient Mice
We have previously isolated several cDNA clones corre- type mice, the SCG is located near the junction of the
external and internal carotid arteries (Figures 2C andsponding to genes whose expression is increased in
P19 mouse embryonic carcinoma cells in association 2E). In the Gfra32/2 mice, however, the SCG was either
missing or markedly reduced in size (Figures 2D and 2F).with retinoic acid±induced differentiation (Fujii et al.,
1997). One of these clones was shown to be derived from Transverse sections of the aberrant SCG from Gfra32/2
mice revealed the presence of few neuronal cells, someGfra3, which we then mapped to mouse chromosome 18
(data not shown). The Gfra3 gene is composed of eight of which appeared to be undergoing degeneration (Fig-
ure 2F).exons and seven introns. To study the role of GFRa3 in
PNS development, we generated mice in which Gfra3 SCG neurons innervate various sites, including the
submandibular gland and the superior tarsus muscle.was ablated by embryonic stem (ES) cell±mediated tar-
geting. A targeting vector was designed to remove ex- Parasympathetic ganglia also innervate these target
sites. We therefore examined the submandibular glandons 4 to 8 of Gfra3 by homologous recombination (Fig-
ure 1A). Eight mutant ES cell lines were obtained (Figure and the superior tarsus muscle with antibodies to tyro-
sine hydroxylase (TH) and to choline acetyltransferase1B), from two of which Gfra31/2 heterozygotes were
generated. The heterozygotes appeared normal and (ChAT); the former antibody detects sympathetic fibers,
whereas the latter detects parasympathetic fibers.were fertile, and their intercrossing resulted in the birth
SCG Defects in Gfra32/2 Mice
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Figure 2. Defects in the SCG of Adult Gfra32/2 Mice
(A and B) External appearance of wild-type (A) and Gfra32/2 (B) adult mice. The Gfra32/2 mice exhibited ptosis.
(C and D) Whole-mount views of the SCG of wild-type (C) and Gfra32/2 (D) mice. The SCG of the wild-type mouse is indicated by red arrowheads
(C). The SCG was missing (D) or severely reduced in size in the mutant animals. Scale bar, 420 mm.
(E and F) Transverse sections of the SCG dissected from wild-type (E) and Gfra32/2 (F) mice. The marked reduction in size of the SCG is
apparent in the mutant animal. Scale bar, 150 mm.
(G±J) Submandibular glands from wild-type (G and I) and mutant (H and J) mice stained with an antibody against TH (G and H) or an antibody
against ChAT (I and J). TH-positive fibers are apparent in the wild-type mice (G) but absent in the mutant (H). ChAT-positive fibers are present
both in wild-type (I) and in mutant (J) mice. Scale bar, 70 mm.
(K±N) The superior tarsus muscle from wild-type (K and M) and mutant (L and N) mice stained with an antibody against TH (K and L) or an
antibody against ChAT (M and N). TH-positive fibers are apparent in the wild-type mice (K) but absent in the mutant (L). ChAT-positive fibers
are present both in wild-type (M) and mutant (N) mice. Scale bar, 50 mm.
(O and P) In situ hybridization anlaysis of Gfra2 (O) and Gfra3 (P) transcripts in the parasympathetic submandibular ganglion from wild-type
mice on P1. Marked expression of Gfra2, but not of Gfra3, was apparent. Scale bar, 75 mm.
(Q and R) Nissl staining of the submandibular ganglion from wild-type (Q) and Gfra32/2 (R) adult mice. The submandibular ganglion was normal
in the mutant animal. Scale bar, 70 mm.
TH-positive fibers were apparent in the submandibular In fact, it is Gfra2, not Gfra3, that is expressed in the
parasympathetic submandibular ganglion (Figures 2Ogland and the superior tarsus muscle of adult wild-type
mice (Figures 2G and 2K). However, TH-positive fibers and 2P). Together, these observations indicate that
Gfra3 is required for normal development of the SCG.were lost in the corresponding sites of Gfra32/2 mice
(Figure 2H and 2L), indicating the lack of the innervation
by SCG. In contrast, ChAT-positive fibers were detected GFRa3 Is Required for the Survival of SCG Neurons
after Birthin the submandibular gland and the superior tarsus mus-
cle of both wild-type (Figures 2I and 2M) and Gfra32/2 We next examined the SCG of Gfra32/2 mice at various
developmental stages. In wild-type animals, the number(Figures 2J and 2N) mice. Consistently, the parasympa-
thetic submandibular ganglia that innervate the sub- of SCG cells increases until birth, reaching a maximum
at postnatal day 1 (P1), and is then maintained throughmandibular gland appeared normal in Gfra32/2 mice (Fig-
ures 2Q and 2R). Thus, the SCG is defective but the adulthood (Figure 3A). In Gfra32/2 mice, although the
SCG cell number is normal at embryonic day (E) 11.5parasympathetic ganglia are preserved in Gfra32/2 mice.
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Figure 3. Decrease in the Number of SCG Cells in Gfra32/2 Mice During Postnatal Development
(A) The number of cells in the SCG of wild-type and Gfra32/2 mice was counted at various developmental stages. Data are from three animals
of each strain.
(B±I) Nissl staining of SCG (B±E) and stellate ganglion (STG) (F±I) neurons from wild-type (B, D, F, and H) and Gfra32/2 (C, E, G, and I) mice
at P1. Higher magnification views of (B), (C), (F), and (G) are shown in (D), (E), (H), and (I), respectively. Many morphologically abnormal neurons
were apparent in the SCG, but not in the stellate ganglion, of mutant mice. Arrowheads in (E) indicate pyknotic nuclei.
(J and K) Ret expression in the P1 SCG from wild-type (J) and Gfra32/2 (K) mice. Ret expression is markedly reduced in the mutant SCG (K).
(L and M) Sections of the P5 SCG from wild-type (L) and Gfra32/2 (M) mice were processed for the TUNEL detection method of apoptotic
nuclei. Increased apoptosis is apparent in the mutant SCG (M).
(N±Q) The innervation of the submandibular gland (N and O) and the superior tarsus muscle (P and Q) were examined at P1 with an anti-TH
antibody. Wild-type mice are shown in (N) and (P); Gfra32/2 mice are shown in (O) and (Q). TH-positive fibers are present in the control (N and
P) but absent in the mutant (O and Q).
Scale bar, 100 mm for (B), (C), (F), (G), (J), and (K); 20 mm for (D), (E), (H), (I), (L), and (M); 90 mm for (N) and (O); and 60 mm for (P) and (Q).
and it continues to increase between E12.5 and P1, it formed in the mutant mice during embryonic develop-
ment appear to undergo cell death after birth.is only 60%±80% of the wild-type value during this latter
period (Figure 3A). The number of SCG neurons in Whereas SCG neurons in wild-type mice at P1 exhibit
a large cell body and nucleus as well as several nucleoliGfra32/2 mice markedly decreased during postnatal de-
velopment, being 50% and 0%±5% of wild-type values (Figures 3B and 3D), Nissl staining revealed that many
of the SCG neurons in Gfra32/2 mice at this age exhibitedat P7 and P60, respectively. Therefore, SCG neurons
SCG Defects in Gfra32/2 Mice
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Figure 4. Expression of Gfra1, Gfra2, Gfra3, and Ret in Developing and Mature SCG
The SCG from wild-type mice at the indicated ages was sectioned and examined by in situ hybridization for the expression of the indicated
genes. Transient drop of Ret expression at E14.5 (H) and of Gfra2 expression at E18.5 (O) was confirmed with four embryos. Scale bar, 50
mm for (A) through (P) and 100 mm for (Q) through (T).
an immature morphology, characterized by a small cell became restricted to a relatively small population of cells
thereafter (Figures 4E, 4I, and 4M); at P5, z20%±30%body and nucleus and an absence of nucleoli (Figures
3C and 3E). Such immature neurons were not apparent of the SCG cells expressed Gfra3 (Figure 4Q). At P60,
however, Gfra3 expression was undetectable in SCGin other ganglia of the mutant mice, including DRG and
trigeminal and stellate ganglia (Figures 3F±3I; data not cells by in situ hybridization (data not shown).
Although expression of Gfra1 was high at E12.5 (Fig-shown), suggesting that the observed histological neu-
ronal anomalies were specific to the SCG. Ret expres- ure 4B), it decreased gradually thereafter (Figures 4F,
4J, and 4N); at P5, Gfra1 mRNA was almost undetectablesion was examined in the SCG of the wild-type and
Gfra32/2 mice at P1. Ret was highly expressed in most (Figure 4R). The expression pattern of Gfra2 (Figures
4C, 4G, 4K, 4O, and 4S) was similar to that of Gfra3,SCG neurons of wild-type mice (Figure 3J). However,
Ret expression was markedly reduced in the mutant with the exception that Gfra2 expression was transiently
downregulated at E18.5 (Figure 4O). Ret mRNA wasSCG (Figure 3K), suggesting that SCG neurons are not
properly differentiated in Gfra32/2 mice. At P5, apoptotic abundant at E12.5, was transiently downregulated at
E14.5, and was then apparent again at E16.5, E18.5, andcell death was apparent in the SCG from mutant mice
(Figure 3M), whereas very few apoptotic cell nuclei were P5 (Figures 4D, 4H, 4L, 4P, and 4T). Thus, all three Gfra
genes and Ret are expressed in both developing andseen in the controls (Figure 3L). Therefore, the progres-
sive loss of the SCG neurons can be attributed, at least mature SCG neurons.
in part, to an increase in apoptosis.
Impaired Projection of SCG Neurons
before Progressive Cell DeathGfra3 Is Expressed in Developing and Mature SCG
Given the abnormal development of the SCG in Gfra32/2 It was unexpected that only 30% of SCG neurons ex-
press Gfra3 at postnatal stages (Figure 4Q), and yetmice, we investigated whether Gfra3 is expressed in the
developing and mature SCG of wild-type mice (Figure inactivation of Gfra3 leads to almost complete loss of
SCG (Figure 3A). It is thus unlikely that GFRa3-mediated4). We also examined expression of Gfra1, Gfra2, and
Ret. Gfra3 transcripts were detected in the SCG during signaling is simply serving as a survival factor for the
Gfra3-expressing subpopulation. An alternative possi-embryonic development between E12.5 and E18.5, as
well as in the mature SCG at P5. Whereas most SCG bility is that SCG neurons undergo cell death due to
their abnormal projection to target organs. We testedcells expressed Gfra3 at E12.5 (Figure 4A), expression
Neuron
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Figure 5. Defect in the Rostral Migration of SCG Precursors in Gfra32/2 Embryos
(A±C) Transverse sections prepared from wild-type and Gfra32/2 embryos at E11.5 (A), E12.5 (B), and E14.5 (C) were analyzed for the number
of cells in sympathetic ganglia. Cell number was then plotted along the anteroposterior axis. Three embryos were analyzed for each stage.
The positions of the cervical vertebrae (C1±C8) served as indicators of the level of sections along the anteroposterior axis. STG, stellate
ganglion.
(D±I) Representative sections from wild-type (D, F, and H) and Gfra32/2 (E, G, and I) E14.5 embryos that were stained with hematoxylin and
eosin. Planes for transverse sections are indicated by arrowheads in (C). SCG and STG precursors are indicated by closed and open arrowheads,
respectively. In the E14.5 wild-type embryo, the future SCG is apparent in (D) but not in (F). However, in the Gfra32/2 mutant, SCG precursors
are apparent in (G) but not in (E), indicating their caudal shift. The position of the stellate ganglion is not affected in the mutant mice (H and
I). Abbreviations; ao, aorta; cca, common carotid artery; ica, internal carotid artery; ng, nodose ganglion; nX, vagus nerve; svc, superior vena
cava; and thy, thyroid primordium. Scale bar, 100 mm for (D) through (I).
this possibility by examining the innervation of the sub- Rostral Migration of SCG Precursor Cells
Is Impaired in Gfra32/2 Embryosmandibular gland and the superior tarsus muscle at P1
(before progressive cell death takes place). At this stage, We next examined the effect of GFRa3 deficiency on
the development of the SCG in more detail by determin-TH-positive fibers were present in both target organs
of wild-type mice (Figures 3N and 3P). In contrast, ing the number and location of SCG precursors in
Gfra32/2 embryos (Figures 5 and 6). The sympatheticTH-positive fibers were absent in the corresponding
sites of Gfra32/2 mice (Figures 3O and 3Q). Therefore, ganglia are derived from the trunk and vagal neural crest
cells. Normally, the precursor cells of the sympatheticprojection of SCG neurons is already impaired before
they undergo cell death. ganglia migrate ventrally through the anterior region of
SCG Defects in Gfra32/2 Mice
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Figure 6. Expression of Gfra3, artemin, and Ret in or near Migrating SCG Precursors
(A±F) Sagittal sections from wild-type (A±C) and Gfra32/2 (D±F) embryos at E11.5 (A and D), E12.5 (B and E), or E14.5 (C and F) were subjected
to in situ hybridization. The developing SCG were detected with a Ret probe (A and D), a mixture of TH and dopamine b-hydroxylase (DBH)
probes (B and E), or a mixture of TH and Ret probes (C and F). At E11.5, the expression pattern of Ret was similar in the wild-type and mutant
embryos. The caudal shift of the mutant SCG is apparent at E12.5 and E14.5 (E and F).
(G±K) Expression of Gfra3 (G and H) and artemin (I±K) in wild-type embryos was examined by whole-mount in situ hybridization at E11.5 (G
and I) and E12.5 (H and J). (K) shows a transverse section of the embryos in (J). The region corresponding to the SCG is marked in (K). At
E11.5, both SCG and stellate ganglion precursors form a uniform column and express Gfra3 (G). At E12.5, SCG and stellate ganglion precursors
are separated and continue to express Gfra3 (H). artemin is not expressed at E11.5 (I) but is expressed within SCG and in a region surrounding
the SCG precursors at E12.5 (J and K). artemin expression at E12.5 was confirmed with three embryos.
Scale bar, 200 mm for (A), (D), (G), and (I); 300 mm for (B), (E), (H), and (J); 500 mm for (C) and (F); and 75 mm for (K).
the somite and reach the dorsal aorta by E10.5. The (Figures 3A). At E12.5, however, the location of the pro-
spective SCG was shifted caudally in the mutant em-precursors become aligned in a uniform column in the
cervical region at E11.5, and, at E12.5, they begin to bryos; the SCG neurons were located between C5 and
C7 (Figures 5B and 6E). In addition, the number of cellsproliferate. Some neurons then enter the postmitotic
stage and begin to extend axons. At the same time, in the SCG at this time was only 70% of that apparent
for wild-type embryos (Figure 3A). In contrast, the futurethe column-like structure of the immature sympathetic
ganglia begins to separate into individual ganglia. SCG stellate ganglion was positioned normally (Figures 5B
and 6E), although the number of cells in this ganglionprecursors are located between the levels of cervical ver-
tebrae C1 and C7 at this stage (Figures 5B and 6B). By was increased by 40% relative to the wild-type value.
The caudal shift of the SCG in mutant embryos wasE14.5, the SCG and stellate ganglion are clearly separated,
with the SCG now located in its final position between C1 more evident at E14.5, when SCG neurons were located
mostly between C5 and C7 (Figures 5C, 5G, and 6F).and C4 (Figures 5C, 5D, and 6C). This morphogenetic
sequence has been attributed to rostral migration of sym- The number of SCG cells was further reduced to 60%
of the wild-type value at this stage, whereas the numberpathetic cells from the lower cervical levels (Rubin, 1985).
In Gfra32/2 embryos, the SCG precursors were posi- of stellate ganglion cells had returned to normal (Figure
5C). These results indicated that SCG precursors aretioned correctly at E11.5 (Figure 5A), suggesting that
their ventral migration was unimpaired. The number of unable to complete the last step of migration to their
final position in Gfra32/2 embryos.neurons in the developing SCG was also normal at E11.5
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Given that the defect in the migration of SCG precur- SCG development and maintenance: (1) the rostral mi-
gration of SCG precursors between E11.5 and E14.5,sors in Gfra32/2 embryos was apparent between E11.5
and E12.5, we examined in more detail the expression and (2) the survival of SCG neurons after birth.
During development of the sympathetic ganglia, sym-of Gfra3, as well as that of Ret and artemin, in the
developing SCG of wild-type embryos at these times pathetic precursor cells first appear along the aorta in
the thoracic region at E10.5 (Rubin, 1985). One day later(Figure 6). Gfra3 was expressed in the SCG precursors
at E11.5 and E12.5 (Figures 6G and 6H). As mentioned (E11.5), these cells form a uniform column at all cervical
levels. Thus, cells of the future SCG reach their generalabove, whereas at E11.5 the precursor cells of the sym-
pathetic ganglia form a uniform column, at E12.5 two destination later than do those of the future thoracic
ganglia. Between E11.5 and E14.5, SCG precursor cellsgroups of the cells (one for the SCG and the other for the
stellate ganglion) are clearly separated. artemin, which accumulate between C1 and C4 levels and form the
primitive SCG. This accumulation of SCG precursor cellsencodes a putative ligand for GFRa3, was not expressed
at E11.5 (Figure 6I), but it was expressed within the SCG has been attributed to their rostral migration from the
lower cervical levels, which eventually become devoidand in the region surrounding the SCG precursors at
E12.5 (Figures 6J and 6K). At E14.5, artemin was found of such cells. The mechanism of this rostral migration
is not known, although active movement, differentialto be expressed in the SCG (data not shown). Ret was
expressed in the sympathetic ganglia, including the cell proliferation, and passive movement due to axonal
growth may contribute. The impaired rostral migrationSCG, at both E11.5 (Figure 6A) and E12.5 (Figure 4D).
Ret expression appeared normal in Gfra32/2 embryos at of SCG precursors in Gfra32/2 mice and the expression
of artemin in the region of these cells at E12.5 in wild-E11.5 (Figure 6D). These expression patterns of Gfra3,
Ret, and artemin are consistent with the notion that type mice suggest that artemin±GFRa3 signaling might
induce proliferation of SCG precursors, or that arteminGFRa3-mediated signaling is required for the final posi-
tioning (rostral migration) of SCG precursors between may act as a chemotropic factor for the migration of
SCG precursors. A similar defect in the rostral migrationE11.5 and E14.5.
of SCG precursors has not been described for any of
the mutant mice lacking various signaling pathway com-Other PNS Ganglia Are Not Affected
ponents associated with the GDNF family of proteins.in Gfra32/2 Mice
However, mice lacking Phox2a, a homeobox transcrip-Although the SCG was most prominently affected in
tion factor expressed in differentiating neurons of theGfra32/2 mice, Gfra3 is widely expressed in other gan-
autonomic nervous system, show both reduced expres-glia, including DRG and cranial ganglia (Baloh et al.,
sion of Ret in developing autonomic ganglia and a defect1998a; Naveilhan et al., 1998; Widenfalk et al., 1998).
(although relatively minor) in rostral migration of SCGWe therefore examined other ganglia of Gfra32/2 mice
for defects. Whereas Gfra22/2 mice show defects in precursors (Morin et al., 1997).
parasympathetic ganglia (Rossi et al., 1999), these gan- With regard to the role of GFRa3 in the survival of
glia appeared normal in Gfra32/2 mice (Figure 2R; data SCG neurons after birth, GFRa3-mediated signaling may
not shown). This difference in phenotype between the exert a trophic effect in these neurons. During embryonic
two types of mutant mice is consistent with the observa- development, Gfra3 mRNA is abundant in peripheral
tion that Gfra2 is highly expressed in developing para- nerves (Figures 1D, 6G, and 6H) (Baloh et al., 1998a;
sympathetic ganglia, whereas Gfra3 is not (Figures 2O Widenfalk et al., 1998), as are Gfra1 and Gfra2 tran-
and 2P). The enteric nervous system of the Gfra32/2 scripts (Treanor et al., 1996), suggesting that Gfra3 is
animals also appeared normal, given that neurons posi- expressed in Schwann cells in developing ganglia. How-
tive for neuron-specific enolase (Figures 7G and 7H) and ever, in adulthood, Gfra3 expression becomes restricted
for b-tubulin (Figures 7I and 7J) were detected in the to neuronal populations (Baloh et al., 1998a). Ret is also
smooth muscle layer of the gut. expressed in neurons (Pachnis et al., 1993). The presence
The total number of neurons in the DRG also appeared of both GFRa3 and Ret in neurons is thus consistent
normal in Gfra32/2 mice at all developmental stages ex- with the notion that GFRa3-mediated signaling exerts
amined (Figure 7Q). The numbers of DRG neurons posi- a trophic action in mature neurons. However, z30% of
tive for calcitonin gene±related protein (CGRP), neurofil- SCG neurons express Gfra3 at postnatal stages, and
aments, or Ret also did not differ between wild-type and yet the lack of GFRa3 leads to loss of .95% of SCG.
mutant animals (Figures 7A±7F and 7Q), suggesting the Therefore, it is unlikely that artemin is simply acting as
absence of abnormalities in the various subpopula- a survival factor for GFRa3-expressing cells. One can
tions of DRG neurons in Gfra32/2 mice. Furthermore, the envisage two alternative possibilities. The first is that
trigeminal ganglion in GFRa3-deficient mice appeared GFRa3-expressing cells may produce survival factors
normal with regard to cell number and location (Figures for other neurons in SCG. The second is that the mis-
7K±7Q). In the developing trigeminal ganglion of both placed SCG that have abnormal projection patterns may
wild-type and Gfra32/2 mice, Ret was widely expressed, die for the lack of target-derived factors. Although we
whereas Gfra1 and Gfra2 were expressed in restricted cannot rigorously exclude the former possibility, our
populations of cells. findings that the innervation by SCG is already abnormal
at P1 (before massive cell death takes place) strongly
Discussion favor the latter possibility.
The phenotype of Gfra32/2 mice differs markedly from
those of mice lacking other GFRa proteins, GDNF, orRole of GFRa3 in SCG Migration and Survival
The phenotype of Gfra3 knockout mice suggests that neurturin, consistent with the idea that GFRa3 does not
contribute to signaling by GDNF or neurturin. In vitroGFRa3-mediated signaling is required for two steps in
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Figure 7. Characterization of Other PNS Ganglia in Gfra32/2 Mice
(A±F) DRG from wild-type (A), (C), and (E) and Gfra32/2 (B), (D), and (F) adult mice were stained with antibodies to CGRP (A and B), to
neurofilaments (NFH) (C and D), or to Ret (E and F).
(G±J) The enteric nervous system from wild-type (G and I) and Gfra32/2 (H and J) adult mice was stained with antibodies to neuron-specific
enolase (NSE) (G and H) or to b-tubulin (bT) (I and J).
(K±P) Trigeminal ganglia from wild-type (K, M, and O) and Gfra32/2 (L, N, and P) mice were examined at P7 for expression of Gfra1 (K and L),
Gfra2 (M and N), and Ret (O and P) by in situ hybridization.
Scale bar, 50 mm for (A) through (F); 30 mm for (G) through (J); and 100 mm for (K) through (P).
(Q) Total cell numbers and various subpopulations of DRG and TG are summarized. There is no significant difference between wild-type and
Gfra32/2 mice.
assays have shown that GFRa3 interacts with artemin functional redundancy among GFRa proteins. The three
Gfra genes, Ret, artemin, and Gdnf are all expressed inbut not with GDNF or neurturin (Baloh et al., 1998b). Our
demonstration both of the importance of GFRa3 in SCG the developing SCG (Pachnis et al., 1993; Durbec et al.,
1996a; Baloh et al., 1997; Trupp et al., 1997; Widenfalkdevelopment and of artemin expression in the region of
the developing SCG is consistent with the hypothesis et al., 1997; this study). Both Ret2/2 and Gfra32/2 mice
show impaired SCG formation, whereas Gdnf2/2 mutantsthat GFRa3 is a component of the physiological receptor
for artemin. However, it remains to be determined show a subtle defect in the SCG (Moore et al., 1996;
Sanchez et al., 1996). However, the SCG appears normalwhether GFRa3 interacts only with artemin. Indeed,
GDNF-deficient mice show a subtle defect in the SCG in mice deficient in GFRa1, GFRa2, or neurturin (Caca-
lano et al., 1998; Enomoto et al., 1998; Heuckeroth et(Moore et al., 1996; Sanchez et al., 1996), suggesting
that GDNF also might interact with GFRa3 in vivo. al., 1999; Rossi et al., 1999). Thus, signaling mediated
by GFRa3±Ret appears to play the predominant role in
SCG formation. The subtle defect in the SCG in Gdnf2/2Functional Redundancy among GFRa Proteins
Although Gfra3 is widely expressed in the developing mice suggests that GDNF also may interact with GFRa3
in vivo. The SCG mutant phenotype is more severe inand mature PNS (Baloh et al., 1998a; Naveilhan et al.,
1998; Nomoto et al., 1998; Widenfalk et al., 1998), Ret2/2 mice than in Gfra32/2 animals: the developing SCG
is already completely lost in the Ret mutants at E12.5Gfra32/2 mice show defects only in the SCG. The lack
of abnormalities in other ganglia is likely attributable to (Schuchardt et al., 1994), whereas it is only moderately
Neuron
734
al., 1993). A probe specific for Gfra3 was derived from the 0.4 kbreduced in size in Gfra3 mutants at this stage. Therefore,
59 terminal region of the mouse cDNA. Probes specific for Gfra1other GFRa±Ret complexes may also contribute to SCG
(corresponding to nucleotides 1±334 of the mouse cDNA), Gfra2development during embryogenesis. Alternatively, Ret
(nucleotides 805±1215), Ret (nucleotides 211±606), or artemin (nu-
may play an additional role in this process independent cleotides 358±642) were generated from fragments obtained by PCR
of GFRa proteins. with an E11.5 Marathon Ready cDNA library (Clonetech) as template.
All probes were verified not to cross-react with transcripts of relatedUnlike Gfra3, Gfra2 is widely expressed in the para-
genes.sympathetic ganglia (Widenfalk et al., 1997). Consistent
with these expression patterns, Gfra22/2 and neurturin-
Histological Analysisdeficient mice show defects in the development of these
Immunohistochemical staining was performed with antibodies to
ganglia (Heuckeroth et al., 1999; Rossi et al., 1999), Ret (MBL), to CGRP (Sigma), to neurofilament H protein (Sigma), to
whereas Gfra12/2 (Cacalano et al., 1998; Enomoto et al., neuron-specific enolase (MBL), to b-tubulin class III (Sigma), to TH
1998) and Gfra32/2 (this study) mice do not. Gfra22/2 (Sigma), or to ChAT (Chemicon and a gift from T. Ichikawa) at dilu-
tions of 1:200, 1:8000, 1:400, 1:1, 1:400, 1:8000, and 1:1000, respec-mice exhibit a drooping of the upper eyelid similar to
tively. Immune complexes were detected with fluorescein isothiocy-that apparent in the Gfra3 mutants. However, the ptosis-
anate±conjugated antibodies to mouse or rabbit immunoglobulin Glike appearance of Gfra2 mutants most likely results
(1:500 dilution, DACO) or with a peroxidase Vectastain kit (Vector
from a reduction in lacrimal secretion caused by the Labs). For determination of the number of neural cells in ganglia,
defects in parasympathetic ganglia (Rossi et al., 1999). animals were fixed by immersion in or transcardial perfusion with
Genes encoding the GFRa proteins, GDNF family 4% paraformaldehyde, embedded in paraffin, and serially sectioned
at 5 mm thickness. Sections were stained with hematoxylin-eosinmembers, and Ret are all expressed in DRG and cranial
or cresyl violet. Cells containing nucleoli were counted in every sixthganglia such as the trigeminal ganglion, but none of the
section, and the total number of cells in a ganglion was estimatedcorresponding knockout mice exhibit defects in DRG or
by adding the cell number for each section and multiplying by six.
cranial ganglia. If Ret is the only b component of the
receptors for GDNF family ligands, other signaling path- Acknowledgments
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to genes whose expression is activated in P19 cells in association
with retinoic acid±induced neural cell differentiation (Fujii et al.,
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